Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-08-12Clinical Trial Update: Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer [Phase 2, Phase 3]
Clinical trial update on dose-dense chemotherapy (ddEC-ddP) for neoadjuvant treatment of HER2-negative breast cancer, spanning Phase 2 and P…
-
CLINICAL_TRIALS trial_result · 2021-08-11Clinical Trial Update: Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer [Phase 1, Phase 2]
Clinical trial evaluating atezolizumab with cobimetinib or idasanutlin in stage IV or unresectable recurrent estrogen receptor-positive brea…
-
CLINICAL_TRIALS trial_result · 2021-08-11Clinical Trial Update: Tucidinostat and Fulvestrant in Hormone-receptor Positive Advanced Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating tucidinostat and fulvestrant in hormone-receptor positive advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: Neo-Adjuvant Study in Triple Negative Breast Cancer Patients [Phase 2]
Phase 2 neo-adjuvant trial in triple-negative breast cancer completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites [NA]
Clinical trial update for Canady Helios cold plasma scalpel at surgical margins and macroscopic tumor sites; status and results data are unc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-08-06Clinical Trial Update: Active Breathing Coordinator-based vs VisionRT-based Deep Inspiration Breath-hold for Radiation for Breast Cancer [NA]
A completed clinical trial comparing Active Breathing Coordinator-based versus VisionRT-based deep inspiration breath-hold strategies for ra…
-
CLINICAL_TRIALS trial_result · 2021-08-06Clinical Trial Update: Imagio Feasibility Multi-Reader, Multi-Case Study [NA]
A completed feasibility multi-reader, multi-case trial studying Imagio for breast cancer with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-08-05Clinical Trial Update: A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment [Phase 3]
Phase 3 trial of trastuzumab emtansine in HER2-positive breast cancer patients who previously received anti-HER2 and chemotherapy; study com…
-
CLINICAL_TRIALS trial_result · 2021-08-05Clinical Trial Update: Analyzing the Composition of Tears to Identify Cancer [Phase 1, Phase 2]
Phase 1/2 trial exploring tear composition as a biomarker approach for cancer detection, involving breast and ovarian cancer cohorts.
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases [Phase 2]
Phase 2 clinical trial evaluating neoadjuvant response-guided treatment for luminal B and luminal A tumors with node metastases in early-sta…
-
CLINICAL_TRIALS trial_result · 2021-07-30Clinical Trial Update: Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC [Phase 3]
Phase 3 trial comparing tesetaxel plus reduced-dose capecitabine versus capecitabine in HER2-negative, HR-positive locally advanced/metastat…
-
FDA approval · 2021-07-29FDA Approved: FULVESTRANT — Original Application (Zydus Lifesciences Limited)
The FDA approved a generic fulvestrant product from Zydus Lifesciences Limited under an Original Application for the treatment of estrogen r…
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Chinese Breast Cancer Patients [Phase 3]
Phase 3 clinical trial evaluating olanzapine for prevention of chemotherapy-induced nausea and vomiting in Chinese breast cancer patients ha…
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: PalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer [Phase 2]
Phase 2 clinical trial update involving palbociclib in premenopausal women with ER-positive/HER2-negative metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-07-27Clinical Trial Update: ADCb (Anlotinib/Docetaxel/Carboplatin) as Neoadjuvant Therapy for Triple-Negative Breast Cancer [Phase 2]
Phase 2 trial of ADCb (Anlotinib/Docetaxel/Carboplatin) as neoadjuvant therapy for breast cancer is ongoing with status not disclosed.
-
CLINICAL_TRIALS trial_result · 2021-07-27Clinical Trial Update: TAK-228 Plus Tamoxifen in Patients With ER-Positive, HER2-negative Breast Cancer [Phase 2]
Phase 2 trial evaluating TAK-228 in combination with tamoxifen for ER-positive, HER2-negative breast cancer has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2021-07-23Clinical Trial Update: Safety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase Inhibitor [Phase 2]
Phase 2 trial update evaluating safety and efficacy of Q-122 in breast cancer patients on tamoxifen or aromatase inhibitors.
-
CLINICAL_TRIALS trial_result · 2021-07-22Clinical Trial Update: Trastuzumab Combined With Pertuzumab for Adjuvant Treatment of Breast Cancer After Neoadjuvant Therapy [Phase 3]
Phase 3 trial evaluating trastuzumab combined with pertuzumab as adjuvant therapy for breast cancer after neoadjuvant treatment is not yet r…
-
FDA approval · 2021-07-20FDA Approved: PIQRAY — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for PIQRAY (alpelisib) by Novartis, updating the label to include a new indication for HR-positive, …
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Palbociclib Combined With an Aromatase Inhibitor in Breast Cancer [Phase 3]
Phase 3 trial evaluating palbociclib in combination with an aromatase inhibitor for breast cancer is reported.
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy [Phase 4]
Phase 4 trial comparing palbociclib plus letrozole with standard neoadjuvant chemotherapy regimens for breast cancer is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT [Phase 3]
A phase 3 randomized trial evaluating albumin-bound paclitaxel as neoadjuvant therapy for triple-negative breast cancer is underway.
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer [Phase 4]
Phase 4 trial comparing albumin-bound paclitaxel plus carboplatin to epirubicin and docetaxel for triple-negative breast cancer is currently…
-
CLINICAL_TRIALS trial_result · 2021-07-19Clinical Trial Update: Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer [Phase 2]
Phase 2 trial of a folate receptor alpha peptide vaccine with GM-CSF in patients with breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: Pyrotinib and Vinorelbine Tartrate Capsules With or Without Inetetamab for First Line Treatment in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer [Phase 2]
Phase 2 clinical trial investigating pyrotinib and vinorelbine tartrate capsules with or without inetetamab for first-line treatment in tras…